FDA approves herbal medicine for COVID-19 clinical trial


The Food and Drugs Authority (FDA) of Ghana has approved a herbal medicine for clinical trial on COVID-19.

Cryptolepis Sanguinolenta, popularly known as Nibima, has been tested in the laboratories of Kwame Nkrumah University of Science and Technology (KNUST).

In a statement, the FDA CEO Delese Darko said the herbal medicine has some “clinical benefits” hence its approval for clinical trials.

“It is hoped that data from this study may be useful to inform policy or be used for scientific judgments and opinions in relation to COVID-19,” the statement read in part.


Please enter your comment!
Please enter your name here